Track record · closed signal

Novo Nordisk A/S (NVO) — closed signal from March 27, 2026

Target reached Published before the outcome was known, scored automatically when the window closed on June 25, 2026.

Predicted vs. what happened

NVO price · publication thesis → realized outcomesplit-adjusted
$36.39 Published $41.48 Target $47.64 Window close $48.24 Peak
$35.00 – $37.50Entry zone — fair-value band
$36.39Published — price the day we called it
$41.48Target — the price the thesis aimed for
$48.24Peak — highest point inside the window, not a realized return
$47.64Window close — end-of-window price, context only

What happened

Target reached

Reached its target in 31 days.

Peak price
$48.24
peak on June 25, 2026 — not a realized return
Peak gain
+32.6%
peak, from the publication price
Window close
$47.64
end-of-window price, context only
Days to target
31
Window
March 27, 2026 – June 25, 2026

The thesis — published March 27, 2026

Predicted growth
+14%
over the measurement window
Target price
$41.48
the price the thesis aimed for
Entry zone
$35.00 – $37.50
the fair-value band we waited for
Price at publication
$36.39
published March 27, 2026
Confidence
77%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

FDA approval of once-weekly insulin Awiqli refreshed the short-term story. The approval expands the insulin business and improves sentiment after recent pressure on the stock. Because the company is in defensive healthcare and not a cyclical growth name, the shares look set for a better rebound over the next three months compared with many oversold peers.

Primary drivers

  • Approval of once-weekly insulin gives a new, near-term focus
  • Strong diabetes and obesity drug lines offer steady demand
  • Healthcare-heavy business suits cautious market conditions
  • Recent selloff creates a clearer rebound opportunity

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.